AntiparkinsoniansDyskinesia-hyperpyrexia syndrome: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1650卷 / 1期

关键词：

D O I：

10.1007/s40278-017-29571-y

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：39 / 39

相关论文

共 50 条

[1] PramipexoleDyskinesia-hyperpyrexia syndrome: case report
Reactions Weekly, 2015, 1547 (1) : 228 - 228
[2] Levodopa/carbidopaParkinsonism hyperpyrexia syndrome: case report
Reactions Weekly, 2020, 1796 (1) : 144 - 144
[3] Ropinirole withdrawalFirst report of parkinsonism hyperpyrexia syndrome: case report
Reactions Weekly, 2014, 1495 (1) : 40 - 40
[4] Levodopa withdrawalParkinsonism-hyperpyrexia syndrome: case report
Reactions Weekly, 2009, 1252 (1) : 28 - 28
[5] Amantadine withdrawalParkinsonism-hyperpyrexia syndrome: case report
Reactions Weekly, 2011, 1357 (1) : 6 - 6
[6] Levodopa/carbidopaParkinsonism-hyperpyrexia syndrome: case report
Reactions Weekly, 2019, 1775 (1) : 286 - 286
[7] Dyskinesia and hyperpyrexia syndrome: A case report and review of the literature
Zu, J.
Raza, H. K.
Chansysouphanthong, T.
Xu, C.
Zhang, W.
Cui, G.
REVUE NEUROLOGIQUE, 2021, 177 (06) : 710 - 713
[8] Entacapone/levodopa/carbidopaDyskinesia hyperpyrexia syndrome: case report
Reactions Weekly, 2020, 1808 (1) : 118 - 118
[9] Levodopa/carbidopaDyskinesia and hyperpyrexia syndrome and worsening of dyskinesia and hyperpyrexia syndrome following medication error: case report
Reactions Weekly, 2021, 1863 (1) : 206 - 206
[10] AntiparkinsoniansDyskinesia and rebound visual impairment: case report
Reactions Weekly, 2023, 1948 (1) : 68 - 68

← 1 2 3 4 5 →